Your browser doesn't support javascript.
Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance.
Dewidar, Omar; Lotfi, Tamara; Langendam, Miranda W; Parmelli, Elena; Saz Parkinson, Zuleika; Solo, Karla; Chu, Derek K; Mathew, Joseph L; Akl, Elie A; Brignardello-Petersen, Romina; Mustafa, Reem A; Moja, Lorenzo; Iorio, Alfonso; Chi, Yuan; Canelo-Aybar, Carlos; Kredo, Tamara; Karpusheff, Justine; Turgeon, Alexis F; Alonso-Coello, Pablo; Wiercioch, Wojtek; Gerritsen, Annette; Klugar, Miloslav; Rojas, María Ximena; Tugwell, Peter; Welch, Vivian Andrea; Pottie, Kevin; Munn, Zachary; Nieuwlaat, Robby; Ford, Nathan; Stevens, Adrienne; Khabsa, Joanne; Nasir, Zil; Leontiadis, Grigorios; Meerpohl, Joerg; Piggott, Thomas; Qaseem, Amir; Matthews, Micayla; Schünemann, Holger J.
  • Dewidar O; Methods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada.
  • Lotfi T; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Langendam MW; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Parmelli E; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada.
  • Saz Parkinson Z; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, Ontario, Canada.
  • Solo K; Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
  • Chu DK; Joint Research Centre, European Commission, Ispra, Lombardia, Italy.
  • Mathew JL; Instituto de Salud Carlos III, Agencia de Evaluación de Tecnologías Sanitarias, Madrid, Spain.
  • Akl EA; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Brignardello-Petersen R; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada.
  • Mustafa RA; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Moja L; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Iorio A; Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
  • Chi Y; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Canelo-Aybar C; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Kredo T; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Karpusheff J; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada.
  • Turgeon AF; Internal Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, Kansas, USA.
  • Alonso-Coello P; Department of Health Product Policy and Standards, World Health Organization, Geneva, Switzerland.
  • Wiercioch W; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Gerritsen A; Yealth Network, Beijing Yealth Technology Co., Ltd, Beijing, China.
  • Klugar M; Cochrane Campbell Global Ageing Partnership, London, UK.
  • Rojas MX; Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau-CIBERESP, Barcelona, Spain.
  • Tugwell P; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
  • Welch VA; Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
  • Pottie K; National Institute for Health and Care Excellence, London, UK.
  • Munn Z; Centre de Recherche du Centre Hospitalier Affilié Universitaire de Québec (CHA), CHA-Hôpital de l'Enfant-Jésus, Université Laval, Québec City, Québec, Canada.
  • Nieuwlaat R; Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, Québec, Canada.
  • Ford N; Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau-CIBERESP, Barcelona, Spain.
  • Stevens A; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Khabsa J; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada.
  • Nasir Z; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, Ontario, Canada.
  • Leontiadis G; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
  • Meerpohl J; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
  • Piggott T; Department of Clinical Epidemiology and Public Health, Institut d'Investigació Biomèdica Sant Pau IIB Sant Pau, Barcelona, Spain.
  • Qaseem A; Department of Medicine, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
  • Matthews M; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Schünemann HJ; Methods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada.
BMJ Evid Based Med ; 2022 Apr 15.
Article in English | MEDLINE | ID: covidwho-2322766
ABSTRACT
An evidence-based approach is considered the gold standard for health decision-making. Sometimes, a guideline panel might judge the certainty that the desirable effects of an intervention clearly outweigh its undesirable effects as high, but the body of supportive evidence is indirect. In such cases, the application of the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach for grading the strength of recommendations is inappropriate. Instead, the GRADE Working Group has recommended developing ungraded best or good practice statement (GPS) and developed guidance under which circumsances they would be appropriate.Through an evaluation of COVID-1- related recommendations on the eCOVID Recommendation Map (COVID-19.recmap.org), we found that recommendations qualifying a GPS were widespread. However, guideline developers failed to label them as GPS or transparently report justifications for their development. We identified ways to improve and facilitate the operationalisation and implementation of the GRADE guidance for GPS.Herein, we propose a structured process for the development of GPSs that includes applying a sequential order for the GRADE guidance for developing GPS. This operationalisation considers relevant evidence-to-decision criteria when assessing the net consequences of implementing the statement, and reporting information supporting judgments for each criterion. We also propose a standardised table to facilitate the identification of GPS and reporting of their development. This operationalised guidance, if endorsed by guideline developers, may palliate some of the shortcomings identified. Our proposal may also inform future updates of the GRADE guidance for GPS.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2022 Document Type: Article Affiliation country: Bmjebm-2022-111962

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2022 Document Type: Article Affiliation country: Bmjebm-2022-111962